Yahoo
Warsaw PLN

Synektik Spólka Akcyjna (SNT.WA)

327.00 -5.80 (-1.74%)
At close: 4:59:48 PM GMT+1
Chart Range Bar
Loading chart for SNT.WA
  • Previous Close 332.80
  • Open 330.40
  • Bid 327.00 x --
  • Ask 330.00 x --
  • Day's Range 325.40 - 331.60
  • 52 Week Range 245.20 - 398.40
  • Volume 44,175
  • Avg. Volume 33,273
  • Market Cap (intraday) 2.789B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 15.72
  • EPS (TTM) 20.80
  • Earnings Date --
  • Forward Dividend & Yield 10.75 (3.23%)
  • Ex-Dividend Date Jan 28, 2026
  • 1y Target Est 373.00

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.

www.synektik.com.pl

231

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

SNT.WA
19.96%
MSCI WORLD (^990100-USD-STRD)
9.06%

1-Year Return

SNT.WA
28.22%
MSCI WORLD (^990100-USD-STRD)
9.89%

3-Year Return

SNT.WA
475.05%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

SNT.WA
1,105.14%
MSCI WORLD (^990100-USD-STRD)
53.16%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 292.26M
Earnings 55.08M
Profit Margin 18.85%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
16.0%
17.0%
18.0%

Analyst Insights

View More

Analyst Price Targets

323.00
373.00 Average
327.00 Current
419.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    44.81%

  • Return on Assets (ttm)

    29.16%

  • Return on Equity (ttm)

    217.63%

  • Revenue (ttm)

    932.97M

  • Net Income Avi to Common (ttm)

    441.16M

  • Diluted EPS (ttm)

    20.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77.27M

  • Total Debt/Equity (mrq)

    19.39%

  • Levered Free Cash Flow (ttm)

    132.3M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: